Authorized Generics In Spotlight At Senate Hearing
Despite suffering a defeat in the Schering-Plough case, the Federal Trade Commission intends to continue fighting authorized generics agreements and has vowed to make its crackdown on so-called reverse payments one...To view the full article, register now.
Already a subscriber? Click here to view full article